Therapy of severe bronchial asthma attacks by nebulized Berodual

Abstract

The therapy by nebulized Berodual was applied for solution of severe bronchial asthma attacks in 42 bronchial asthma patients. The drug was well-tolerated by all the patients. Against the background of such therapy a number of asthma attacks was diminished in 100% of cases and those quite ceased in 7 patients from 42 ones. A need of beta-2-agonists inhalations was reduced almost in 3 times. Doses of corticosteroids were decreased in 15 patients from 38 ones. An analyze of peak flow rate, peak expiratory flow for one second and lung vital capacity values demonstrated their reliable growth. So, the therapy by nebulized Berodual is thought to be optimal from the point of efficacy and safety for intensive treatment of bronchial asthma patients who were admitted to a hospital because of bronchial asthma attacks arising.